newsfilter
← Latest News
Business Wire·

Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome

Data presented at the 2025 American Epilepsy Society Annual Meeting Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), today announced the presentation of initial open-label extension (OLE) data from the company's